Combined Deletion of Y1, Y2, and Y4 Receptors Prevents Hypothalamic Neuropeptide Y Overexpression-Induced Hyperinsulinemia despite Persistence of Hyperphagia and Obesity
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Neuropeptide Y (NPY) is a key regulator of energy homeostasis and is implicated in the development of obesity and type 2 diabetes. Whereas it is known that hypothalamic administration of exogenous NPY peptides leads to increased body weight gain, hyperphagia, and many hormonal and metabolic changes characteristic of an obesity syndrome, the Y receptor(s) mediating these effects is disputed and unclear. To investigate the role of different Y receptors in the NPY-induced obesity syndrome, we used recombinant adeno-associated viral vector to overexpress NPY in mice deficient of selective single or multiple Y receptors (including Y1, Y2, and Y4). Results from this study demonstrated that long-term hypothalamic overexpression of NPY lead to marked hyperphagia, hypogonadism, body weight gain, enhanced adipose tissue accumulation, hyperinsulinemia, and other hormonal changes characteristic of an obesity syndrome. NPY-induced hyperphagia, hypogonadism, and obesity syndrome persisted in all genotypes studied (Y1−/−, Y2−/−, Y2Y4−/−, and Y1Y2Y4−/− mice). However, triple deletion of Y1, Y2, and Y4 receptors prevented NPY-induced hyperinsulinemia. These findings suggest that Y1, Y2, and Y4 receptors under this condition are not crucially involved in NPY’s hyperphagic, hypogonadal, and obesogenic effects, but they are responsible for the central regulation of circulating insulin levels by NPY.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604 · cited 1×
“Moreover, food intake in obese human subjects was shown to be inhibited by a preferential Y2/Y5 receptor agonist (PYY)3–36 (31) and ICV administration of PYY3–36 or other Y2 receptor agonists has been shown to reduce feeding and body weight in rodents (19, 32, 33).”
BackgroundSTAT3 signalling is required for leptin regulation of energy balance but not reproduction
Bates, S. H., Stearns, W. H., Dundon, T. A., Schubert, M., Tso, A. W. K., Wang, Y., Banks, A. S., Lavery, H. J., Haq, A. K., Maratos-Flier, E., et al. (2003) · Nature · doi:10.1038/nature01388 · Cited by 1,010 · cited 1×
“This dissociation of mechanisms of action of NPY is reminiscent of leptin signaling, whereby specific interruption of leptin receptor-signal transducer and activator of transcription 3 signaling results in obesity, hyperphagia, and hyperinsulinemia, whereas complete absence of leptin receptors as in db/db mice results…”
BackgroundNeuropeptide Y: Direct and indirect action on insulin secretion in the rat
Moltz, J. H., & McDonald, J. K. (1985) · Peptides · doi:10.1016/0196-9781(85)90443-7 · Cited by 213 · cited 1×
“In addition to its central effect on insulin release, NPY also acts directly on the pancreas to inhibit both basal and stimulated insulin release (54).”
BackgroundMorgan, D. G., Kulkarni, R. N., Hurley, J. D., Wang, Z. L., Wang, R. M., Ghatei, M. A., Karlsen, A. E., Bloom, S. R., & Smith, D. M. (1998) · Diabetologia · doi:10.1007/s001250051095 · Cited by 79 · cited 2×
“So far, Y1 is the only receptor subtype identified in the pancreas (61, 63); whether Y2 and Y4 receptors are also present remains to be tested.”
Background
Cited by
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Johnen, H., Lin, S., Kuffner, T., Brown, D. A., Tsai, V. W.-W., Bauskin, A. R., Wu, L., Pankhurst, G., Jiang, L., Junankar, S., et al. (2007) · Nature Medicine · doi:10.1038/nm1677 · Cited by 612
“8 mm; this corresponded to the ARC hypothalamic nucleu”
BackgroundSelf-citationShi, Y.-C., Lau, J., Lin, Z., Zhang, H., Zhai, L., Sperk, G., Heilbronn, R., Mietzsch, M., Weger, S., Huang, X.-F., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.006 · Cited by 266
Self-citationCentral Resistin Induces Hepatic Insulin Resistance via Neuropeptide Y
Singhal, N. S., Lazar, M. A., & Ahima, R. S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2443-07.2007 · Cited by 75
A talk between fat tissue, gut, pancreas and brain to control body weight
Wilson, J. L., & Enriori, P. J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.08.022 · Cited by 39
Metadata
- Authors
- Lin, E.-J. D., Sainsbury, A., Lee, N. J., Boey, D., Couzens, M., Enriquez, R., Slack, K., Bland, R., During, M. J., & Herzog, H.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-11-01
- Volume
- 147
- Issue
- 11
- Pages
- 5094-5101
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2060766383
- Cited by
- 51
- References
- 4
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.